Xinlong Health has released its 2026 interim report. The company's total operating revenue was 717 million yuan, net profit attributable to the parent company was 8.0345 million yuan, and net cash inflow from operating activities was 59.4304 million yuan. The company's latest asset-liability ratio was 46.62 percent, an increase of 3.00 percentage points compared with the same period last year. The latest gross margin was 12.98 percent, a decrease of 0.16 percentage points from the previous quarter. The latest return on equity was 0.99 percent, and diluted earnings per share was 0.02 yuan. The company's latest total asset turnover was 0.43 times, and the latest inventory turnover was 2.81 times. The number of shareholders was 24,100, and the top ten shareholders held 196 million shares, accounting for 53.60 percent of the total share capital.
HL Corp ShenzhenInterim report shows modest net profit and declining margins, mixed financials.